Cellectis SA (CLLS)
3.92
-0.15
(-3.69%)
USD |
NASDAQ |
May 15, 16:00
3.99
+0.07
(+1.79%)
After-Hours: 20:00
Cellectis Shareholders Equity (Quarterly) : 59.92M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 207.90M |
| Grifols SA | 6.289B |
| Akari Therapeutics Plc | 28.33M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 32.72M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 289.19M |
| Total Liabilities (Quarterly) | 229.27M |
| Debt to Equity Ratio | 1.812 |
| Current Ratio | 1.521 |
| Net Debt Paydown Yield | 0.07% |